Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Ordinary Shares / American Depositary Shares
Shares outstanding: 384,317,619
Number of holders: 14
Total 13F shares, excl. options: 4,230,788
Shares change: +495,709
Total reported value, excl. options: $4,907,708
Value change: +$580,032
Number of buys: 6
Number of sells: -8
Price: $1.16

Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2025

19 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q2 2025.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,230,788 shares of 384,317,619 outstanding shares and own 1.1% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (1,614,134 shares), ORBIMED ADVISORS LLC (940,990 shares), SPHERA FUNDS MANAGEMENT LTD. (738,048 shares), Yelin Lapidot Holdings Management Ltd. (578,291 shares), Ikarian Capital, LLC (213,052 shares), RHUMBLINE ADVISERS (39,875 shares), KESTRA PRIVATE WEALTH SERVICES, LLC (31,241 shares), BOOTHBAY FUND MANAGEMENT, LLC (26,189 shares), JANE STREET GROUP, LLC (20,569 shares), and BNP PARIBAS FINANCIAL MARKETS (13,900 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.